First Trust Advisors »

Crispr Therapeutics shares owned by First Trust Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by First Trust Advisors from 13F filings

Historical chart of First Trust Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by First Trust Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by First Trust Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $404k 8.9k 45.39
2023-06-30 $5.4M 96k 56.14
2022-12-31 $254k 6.2k 40.65
2022-09-30 $4.0M 62k 65.35
2022-06-30 $524k 8.6k 60.82
2022-03-31 $526k 8.4k 62.75
2021-12-31 $517k 6.8k 75.73
2021-09-30 $4.7M 42k 111.92
2021-03-31 $3.8M 31k 121.86
2020-12-31 $10M 65k 153.10
2020-09-30 $5.5M 66k 83.64
2020-06-30 $5.1M 69k 73.49
2020-03-31 $3.9M 91k 42.41
2019-09-30 $987k 24k 40.98
2019-03-31 $889k 25k 35.71
2018-12-31 $968k 34k 28.58
2018-09-30 $4.1M 93k 44.35
2018-06-30 $5.0M 85k 58.76